Placebo treatment is effective differently in different diseases - But is it also harmless? A brief synopsis

Science and Engineering Ethics

Volumn 10, Issue 1, 2004, Pages 151-155

  Weihrauch, Thomas R ^a,b  

^a BAYER AG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Adverse drug reactions; Clinical trials; Declaration of helsinki; Efficacy; Ethics; Placebo

Indexed keywords

ACARBOSE; ENDORPHIN; GLUCOSE; HYDROTALCITE; IPSAPIRONE; NIMODIPINE; NISOLDIPINE; PLACEBO;

ADVERSE DRUG REACTION; ANGINA PECTORIS; ANXIETY DISORDER; CARDIOVASCULAR EFFECT; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HUMAN; INFORMED CONSENT; SYMPTOMATOLOGY; TACHYCARDIA; XEROSTOMIA;

EID: 1242284494     PISSN: 13533452     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11948-004-0072-y     Document Type: Conference Paper

References (8)

1. Weihrauch TR and Gauler TC (1999): Placebo - Efficacy and adverse effects in controlled clinical trials, Drug Res. 49 (I), 5: 385-93.
2. World Medical Association of Helsinki(as revised Edinburgh 2000), www.wma./net/policy.
3. Lewis JA et al. (2002) Placebo controlled trials and the Declaration of Helsinki, Lancet 359: 1337-40.
4. Temple R, Ellenberg SS (2000) Placebo-controlled trials and active-controlled trials in the evaluation of new treatments, part1: ethical and scientific issues, Ann Intern Med 133: 455-62.
5. Pigeot I, Schäfer J, Röhmel J, Hauschke D (2003) Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo: Stat. Med. 22: 883-899.
6. EMEA/CPMP Position statement on the use of placebo in clinical trials with regard to the revised Declaration of Helsinki, www.emea.eu.int/index/ indexh1.htm (28 June 2001).
7. Huston P and Petersen R (2001) Withholding proven treatment in clinical research, NEJM (editorial) 345: 912-914.
8. Anonymous: Choice of control group in clinical trials, ICH E10 (2000). London: EMEA http://www.ich.org/ich7.html.